Health
Results: 7033-7044 of 8097

Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024

FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara® (Ustekinumab)

Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation








